A pilot study on risk factors and p53 gene expression in colorectal cancer
1996

Risk Factors and p53 Gene Expression in Colorectal Cancer

Sample size: 70 publication Evidence: moderate

Author Information

Author(s): M Fredrikson, 0 Axelson, X-F Sun, G Arbman, E Nilsson, B Nordenskjöld, R Sjodahl, P Söderkvist

Primary Institution: University Hospital, Linkoping, Sweden

Hypothesis

What are the specific risk factors associated with p53 gene expression in colorectal cancer?

Conclusion

The study suggests that alcohol use and hydralazine-containing antihypertensive drugs are associated with p53-positive colorectal tumors.

Supporting Evidence

  • 42% of colorectal cancer cases showed p53-positive staining.
  • Hydralazine was strongly associated with p53-positive tumors.
  • Alcohol intake increased the risk for p53-positive tumors.

Takeaway

This study looked at how certain things like drinking alcohol and taking specific medications might affect a gene related to cancer in the intestines.

Methodology

The study combined data from two case-control studies involving colorectal cancer patients and controls, using questionnaires and immunohistochemical staining for p53 expression.

Potential Biases

Potential bias due to the small number of cases and controls and the reliance on self-reported data.

Limitations

The small sample size and the possibility of misclassification of p53 positivity due to alternative mechanisms.

Participant Demographics

Patients diagnosed with colorectal cancer aged 33-93 years, with a mean age of 64 years.

Statistical Information

P-Value

3.4 for alcohol intake in p53-positive tumors; 15 for hydralazine in p53-positive tumors.

Confidence Interval

1.1 - 10 for alcohol; 2.5 - 91 for hydralazine.

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication